- Home
- BIOA vs CADL Comparison
BIOA vs CADL Comparison
Compare BIOA & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- CADL
- Stock Information
- Founded
- BIOA 2015
- CADL 1999
- Country
- BIOA United States
- CADL United States
- Employees
- BIOA N/A
- CADL N/A
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- BIOA Health Care
- CADL Health Care
- Exchange
- BIOA Nasdaq
- CADL Nasdaq
- Market Cap
- BIOA N/A
- CADL 159.1M
- IPO Year
- BIOA 2024
- CADL 2021
- Fundamental
- Price
- BIOA $6.08
- CADL $8.80
- Analyst Decision
- BIOA Hold
- CADL Strong Buy
- Analyst Count
- BIOA 3
- CADL 1
- Target Price
- BIOA $18.00
- CADL $19.00
- AVG Volume (30 Days)
- BIOA 1.7M
- CADL 9.7M
- Earning Date
- BIOA 02-15-2025
- CADL 11-14-2024
- Dividend Yield
- BIOA N/A
- CADL N/A
- EPS Growth
- BIOA N/A
- CADL N/A
- EPS
- BIOA N/A
- CADL N/A
- Revenue
- BIOA N/A
- CADL N/A
- Revenue This Year
- BIOA N/A
- CADL N/A
- Revenue Next Year
- BIOA N/A
- CADL N/A
- P/E Ratio
- BIOA N/A
- CADL N/A
- Revenue Growth
- BIOA N/A
- CADL N/A
- 52 Week Low
- BIOA $3.85
- CADL $1.10
- 52 Week High
- BIOA $26.62
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- CADL 61.29
- Support Level
- BIOA N/A
- CADL $7.90
- Resistance Level
- BIOA N/A
- CADL $10.38
- Average True Range (ATR)
- BIOA 0.00
- CADL 1.81
- MACD
- BIOA 0.00
- CADL 0.32
- Stochastic Oscillator
- BIOA 0.00
- CADL 43.80
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.